Unlike fine wine, humans don’t get better with age, especially when we are talking about AGEs (Advanced Glycation End-products). This week we continue our Homerun Slides series on these damaging compounds and how they affect each organ in the body. Our journey into the psychology of diabetes has reached the grade …
Read More »Monthly Archives: November 2011
Psychology in Diabetes Care, 2nd Ed: Diabetes in Children, Part 6
Edited by Frank J. Snoek and T. Chas Skinner Diabetes in School-aged Children 1.6 Family Factors Related to Glycemic Control and Adherence Due to the relatively small number of children under the age of 6 with diabetes, there have been few, if any, studies on how family environment variables …
Read More »Overview of AGEs, Part 2 of 4
In this week’s set of Homerun Slides, we review AGEs and their relation to complications of diabetes including retinopathy, nephropathy, neuropathy and macrovascular disease….
Read More »Letter from the Editor: Shrink and Move Video, Telehealth
This week finishes off National Diabetes Month, and over the past few weeks I have received countless videos, emails and tweets about diabetes. I have also noticed that more and more of my patients are watching You Tube, Netflix, sports or TV on their smartphones or tablets. Last week I …
Read More »YouTube Video for National Diabetes Month
YouTube Video for National Diabetes Month Shrink and Move: Accept Your Diabetes is a great tool to show to your patients with diabetes especially if they are new. Click on this link to watch it now.
Read More »iPro2
iPro2 The FDA has approved Medtronic’s iPro2, a next-generation professional continuous glucose monitoring system (CGMS). The new 6-day evaluation system is designed to make continuous glucose monitoring easy for health care professionals and patients to use. It can be used to identify nocturnal hypoglycemia or postprandial hyperglycemia. The setup procedure …
Read More »Sitagliptin/Pioglitazone Combo Application Withdrawn in EU
Sitagliptin/Pioglitazone Combo Application Withdrawn in EU Merck Sharp & Dohme Inc. has withdrawn its marketing authorization application for sitagliptin/pioglitazone (Janacti).
Read More »More Physicians Embrace Web-Based Health Solutions
Datamonitor, the London-based market research firm, estimates the market for telehealth services in the U.S. and Europe will grow from $3 billion in 2009 to nearly $8 billion by 2012. A 2010 survey by Intel also found that 89% of health care decision makers believe telehealth will transform health care …
Read More »Diabetes Can Increase Risk of Bladder Cancer Recurring
A new study has claimed that having diabetes could heighten the chances of the recurrence of bladder cancer, as well as promoting its progression. The research argued that diabetes could be an independent predictor of non-muscle invasive bladder cancer (NMIBC) recurring or progressing. The study which involved 251 patients found …
Read More »Four Drugs Responsible for 100,000 Emergency Hospitalizations for Seniors from Adverse Drug Events Yearly
Two thirds involve just a handful of anticoagulants and diabetes medications according to a study. The study, by researchers from the CDC, singles out 4 drugs and drug classes: warfarin, oral antiplatelet medications, insulins, and oral hypoglycemic agents. Alone or together, they account for 67% of emergency ADE hospitalizations of …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.